Our breakthrough, proprietary technology platform engineered to enhance drug absorption
End-to-end, in-house control of formulation, development, and manufacturing capabilities
Our proprietary cannabinoid composition for the management of pain and inflammation
Partnering with the world’s leading research institutions and doctors to support FDA-authorized investigator-initiated clinical trials
Learn more about cannabidiol from the medical community and regulators
We are modernizing the way medicines are taken
Experts in drug development and delivery, manufacturing, and commercialization
Recent media coverage regarding Orcosa
Company news and announcements
Mr. Sturchio is an accomplished life sciences executive, business strategist and advisor. Prior to his current role as General Counsel and Executive Committee member of Immatics N.V., he served as General Counsel and Senior Leadership member at Abeona Therapeutics and as Global General Counsel of Advanced Accelerator Applications (AAA), a Novartis company, where he was responsible for worldwide legal, compliance and IP functions across 22 sites in 13 countries. Before joining AAA, Mr. Sturchio worked in the Corporate Securities and Life Sciences departments of Greenberg Traurig LLP and Day Pitney LLP for over fifteen years, where he advised pharmaceutical and life sciences executives and boards of directors on regulatory, transactional, corporate strategy, M&A and securities matters.
He received a J.D. from Seton Hall University and a B.A. in psychology from Villanova University. Mr. Sturchio has written and lectured extensively in the areas of executive leadership, life sciences and corporate securities matters.